Each factor with its sector median and, where it's reported per quarter, its last 12 quarters.
BIOSector12 quartersMarket cap$9.73B$9.67BEnterprise value$10.41B$10.41BAvg daily $ volume$100.71M$132.68MDaily turnover1.0%1.3%
BIOSector12 quartersRevenue CAGR 3y-2.2%9.5%Revenue CAGR 5y-2.1%8.9%Revenue growth YoY-0.1%8.7%Revenue acceleration−1.2 pp+0.0 ppFCF growth YoY-4.8%5.9%FCF conversion158.8%130.8%Forward growth (HoM est.)-1.1%9.8% BIOSector12 quartersP/E (trailing)43.7×27.6×P/E (forward, HoM est.)44.2×25.2×P/E vs. sector1.7×1.0×PEG (HoM est.)—3.12EV/EBITDA—17.5×EV/Sales4.0×3.3×FCF yield3.4%3.6%Dividend yield0.0%0.0%Shareholder yield1.3%1.2%
BIOSector12 quartersQuality checks passed23ROIC0.4%9.2%Gross profitability13.1%32.6%Gross margin51.9%60.1%Gross margin Δ 3y−2.1 pp−0.1 ppOperating margin2.1%10.6%Operating margin Δ 3y−11.1 pp+0.9 ppDebt/equity0.2×0.7×Net debt/EBITDA—2.0×Interest coverage1.1×4.9×Share count Δ 3y-8.9%-0.3%Stock compensation / revenue2.3%1.8%Accruals ratio-2.6%-4.3% BIOSector12 quartersDays to next report613
BIOSector12 quartersInsider buys (90d)00Insiders buying (90d)00Insider net value (90d)$0$0Institutional ownership72.6%99.6%Institutional Δ QoQ−2.2 pp+1.1 ppConviction funds net buying—−0.0 ppActive managers net buying+0.3 pp+0.1 ppActive funds net buying+0.1 pp+0.0 ppDays to cover4.274.29Short % of shares out4.4%6.0%Short interest Δ+0.7 pp+0.1 pp